Perceptive Advisors’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Hold |
0
| – | – | – | 99 |
|
|
2023
Q3 | – | Sell |
-812,037
| Closed | -$74M | – | 89 |
|
|
2023
Q2 | $74M | Buy |
812,037
+256,693
| +46% | +$23.4M | 2.14% | 14 |
|
|
2023
Q1 | $36.6M | Buy |
+555,344
| New | +$36.6M | 1.08% | 28 |
|
|
2022
Q4 | – | Sell |
-366,400
| Closed | -$25M | – | 96 |
|
|
2022
Q3 | $25M | Buy |
366,400
+45,100
| +14% | +$3.08M | 0.73% | 38 |
|
|
2022
Q2 | $14.5M | Sell |
321,300
-1,160,400
| -78% | -$52.5M | 0.46% | 50 |
|
|
2022
Q1 | $75.3M | Buy |
1,481,700
+30,000
| +2% | +$1.52M | 1.51% | 18 |
|
|
2021
Q4 | $68.6M | Buy |
1,451,700
+836,700
| +136% | +$39.6M | 1.06% | 25 |
|
|
2021
Q3 | $20.3M | Sell |
615,000
-46,162
| -7% | -$1.52M | 0.29% | 68 |
|
|
2021
Q2 | $41.8M | Buy |
+661,162
| New | +$41.8M | 0.54% | 47 |
|
|
2020
Q3 | – | Sell |
-11,418
| Closed | -$373K | – | 127 |
|
|
2020
Q2 | $373K | Hold |
11,418
| – | – | 0.01% | 121 |
|
|
2020
Q1 | $327K | Buy |
+11,418
| New | +$327K | 0.01% | 105 |
|